Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid in High Tibial Osteotomy
NCT04653623Unknown
- Sponsor
- The Catholic University of Korea
- Start
- Oct 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of tranexamic acid (2 arms), sponsored by The Catholic University of Korea. Primary endpoint: Hemoglobin level at 2 weeks. Status: unknown.
02
Drugs
tranexamic acid
Beyond the preview
Go deeper on NCT04653623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04653623.